STOCKHOLM, June 22, 2026 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the company has entered into a research and collaboration agreement with Eli Lilly and Company regarding a potential new treatment combining BioArctic's proprietary...
Hence then, the article about bioarctic and lilly sign research and collaboration agreement combining lilly compound with bioarctic s braintransporter technology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology )
Also on site :
- California is getting ready to increase a health insurance tax — will it affect your premium?
- There Are 3 Groundbreaking Alzheimer’s Treatments on the Horizon—a Neurologist Explains How They Work
- The union behind California’s billionaire tax is blinking, but Gavin Newsom wants to inflict total defeat